Anika Therapeutics announces $40M share repurchase program

In addition, the Anika board of directors has authorized a $40M share repurchase program, $15M of which will be effected through a 10b5-1 plan to be completed by June 30, 2025, and the remainder of which will be purchased in the open market through June 30, 2026, subject to prevailing stock prices, general economic and market conditions, and other considerations. This new buyback authorization replaces the company’s share repurchase program announced in April 2023.